cp 46665 has been researched along with meglumine in 1 studies
Studies (cp 46665) | Trials (cp 46665) | Recent Studies (post-2010) (cp 46665) | Studies (meglumine) | Trials (meglumine) | Recent Studies (post-2010) (meglumine) |
---|---|---|---|---|---|
17 | 0 | 0 | 4,168 | 413 | 1,399 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adinolfi, LE; Bonventre, PF | 1 |
1 other study(ies) available for cp 46665 and meglumine
Article | Year |
---|---|
Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1).
Topics: Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis, Visceral; Lymphokines; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Organometallic Compounds; Piperidines; Thioglycolates | 1985 |